Prostaglandin derivatives
US8058467B2 · kind B2 · utility
8Cited by
10References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2011 |
| Grant date | Nov 15, 2011 |
| Priority date | — |
| Expiry date | Feb 11, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.